Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

[The proteasome and malignant hemopathies].

T Lavabre-Bertrand1, L Henry, I Guiraud

  • 1Laboratoire de Biologie Cellulaire et de Cytogénétique Moléculaire. Faculté de Médecine de Montpellier-Nimes, France. t-lavabre@usa.net

Morphologie : Bulletin De L'Association Des Anatomistes
|October 26, 2000
PubMed
Summary

Cellular proteasomes change during leukaemic cell differentiation, with decreased nuclear and cytoplasmic levels but increased cell membrane expression. Plasma proteasome levels may aid in cancer diagnosis and monitoring.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Measurement of the Prompt D^{0} Nuclear Modification Factor in p-Pb Collisions at sqrt[s_{NN}]=8.16  TeV.

Physical review letters·2023
Same author

Measurement of the Branching Fractions B(B^{0}→pp[over ¯]pp[over ¯]) and B(B_{s}^{0}→pp[over ¯]pp[over ¯]).

Physical review letters·2023
Same author

Measurement of the Time-Integrated CP Asymmetry in D^{0}→K^{-}K^{+} Decays.

Physical review letters·2023
Same author

Observation of a Resonant Structure near the D_{s}^{+}D_{s}^{-} Threshold in the B^{+}→D_{s}^{+}D_{s}^{-}K^{+} Decay.

Physical review letters·2023
Same author

Evidence for Modification of b Quark Hadronization in High-Multiplicity pp Collisions at sqrt[s]=13  TeV.

Physical review letters·2023
Same author

Test of Lepton Universality in b→sℓ^{+}ℓ^{-} Decays.

Physical review letters·2023

Area of Science:

  • Cell Biology
  • Molecular Biology
  • Biochemistry

Context:

  • Proteasomes are critical cellular machinery for protein degradation, essential for normal cell function and immune surveillance.
  • Understanding proteasome dynamics is key to deciphering cellular processes, including malignant transformation and differentiation.
  • Leukemic cell lines (U937, CCRF-CEM) serve as models to study cancer cell behavior and therapeutic responses.

Purpose:

  • To investigate the changes in proteasome expression and localization during in vitro differentiation of leukaemic cell lines.
  • To explore the potential of plasma proteasome levels as biomarkers for hematologic malignancies and solid tumors.
  • To assess the correlation between plasma proteasomes, tumor burden, and treatment response.

Summary:

Related Experiment Videos

  • Proteasome expression and localization were analyzed in U937 and CCRF-CEM cells during differentiation induced by PMA and Vitamin D/retinoic acid.
  • Differentiation led to decreased nuclear and cytoplasmic proteasome levels, with increased expression on the cell membrane and in supernatants.
  • An ELISA assay revealed distinct plasma proteasome concentrations in cancer patients versus healthy donors, correlating with LDH levels and treatment.

    • Impact:

    • Findings suggest a role for cellular proteasomes in the malignant differentiation process, highlighting qualitative expression changes.
    • Plasma proteasomes emerge as a promising tool for cancer diagnosis, prognosis, and therapeutic monitoring, potentially reflecting more than just tumor mass.
    • This research provides insights into proteasome function in cancer and supports their utility as clinical biomarkers.